Lenvatinib plus pembrolizumab for advanced kidney cancer
The final survival information from the phase 3 CLEAR study [...]
The final survival information from the phase 3 CLEAR study [...]
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
Immunotherapy combinations are becoming the standard treatment for people with [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
Further follow-up data from the phase 3 CLEAR study with [...]
Lenvatinib plus pembrolizumab has already been shown to improve survival [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
Non-clear cell kidney cancer is a group of different subtypes [...]